DAFNA Capital Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Hold |
636,103
| – | – | 0.29% | 56 |
|
|
2025
Q1 | $1.01M | Buy |
+636,103
| New | +$1.01M | 0.29% | 57 |
|
|
2020
Q1 | – | Sell |
-11,077
| Closed | -$3.7M | – | 85 |
|
|
2019
Q4 | $3.7M | Sell |
11,077
-825
| -7% | -$276K | 1.27% | 21 |
|
|
2019
Q3 | $3.84M | Buy |
11,902
+3,568
| +43% | +$1.15M | 1.44% | 21 |
|
|
2019
Q2 | $3.59M | Hold |
8,334
| – | – | 1.35% | 24 |
|
|
2019
Q1 | $4.71M | Buy |
8,334
+825
| +11% | +$466K | 2.03% | 14 |
|
|
2018
Q4 | $2.23M | Buy |
7,509
+3,176
| +73% | +$942K | 1.11% | 28 |
|
|
2018
Q3 | $3.07M | Hold |
4,333
| – | – | 1.26% | 28 |
|
|
2018
Q2 | $2.53M | Buy |
+4,333
| New | +$2.53M | 1.19% | 26 |
|